Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?

This invited review follows the oral presentation “To Sequence or Not to Sequence, That Is Not the Question; But ‘When, Who, Which and What For?’ Is” given during the State of the Art session “Translational Genomics in Thrombosis: From OMICs to Clinics” of the International Society on Thrombosis and...

Full description

Saved in:
Bibliographic Details
Published inJournal of thrombosis and haemostasis Vol. 22; no. 7; pp. 1826 - 1834
Main Authors Trégouët, David-Alexandre, Morange, Pierre-Emmanuel
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.07.2024
Wiley
Subjects
Online AccessGet full text
ISSN1538-7836
1538-7933
1538-7836
DOI10.1016/j.jtha.2024.04.004

Cover

More Information
Summary:This invited review follows the oral presentation “To Sequence or Not to Sequence, That Is Not the Question; But ‘When, Who, Which and What For?’ Is” given during the State of the Art session “Translational Genomics in Thrombosis: From OMICs to Clinics” of the International Society on Thrombosis and Haemostasis 2023 Congress. Emphasizing the power of next-generation sequencing technologies and the diverse strategies associated with DNA variant analysis, this review highlights the unresolved questions and challenges in their implementation both for the clinical diagnosis of venous thromboembolism and in translational research.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1538-7836
1538-7933
1538-7836
DOI:10.1016/j.jtha.2024.04.004